FASLG and lymphoma: Findings revealed that treatment with the lymphoma-derived exosomes downregulate the expression of NKG2D on NK cells and decrease protein levels of perforin, granzyme B, TNF-α, and IFN-γ which might be Fas-L/Survivin dependent [86].